These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5946418)

  • 41. Reassessing the diagnostic yield of saturation biopsy of the prostate.
    Ashley RA; Inman BA; Routh JC; Mynderse LA; Gettman MT; Blute ML
    Eur Urol; 2008 May; 53(5):976-81. PubMed ID: 17997028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk.
    Igel TC; Knight MK; Young PR; Wehle MJ; Petrou SP; Broderick GA; Marino R; Parra RO
    J Urol; 2001 May; 165(5):1575-9. PubMed ID: 11342920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Needle biopsies of the prostate: what constitutes adequate histologic sampling?
    Lane RB; Lane CG; Mangold KA; Johnson MH; Allsbrook WC
    Arch Pathol Lab Med; 1998 Sep; 122(9):833-5. PubMed ID: 9740145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Leukemic infiltration and prostatic adenocarcinoma].
    Lobel B; Hervé PY; Le Prise PY; Ramée MP; Bauchart J
    Nouv Presse Med; 1979 Oct; 8(40):3272. PubMed ID: 534193
    [No Abstract]   [Full Text] [Related]  

  • 45. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens.
    Arista-Nasr J; Keirns C
    Am J Clin Pathol; 1998 Sep; 110(3):409. PubMed ID: 9728620
    [No Abstract]   [Full Text] [Related]  

  • 46. Broadsheet number 45: thin core biopsy of prostate. The Royal College of Pathologists of Australia.
    Delahunt B; Nacey JN
    Pathology; 1998 Aug; 30(3):247-56. PubMed ID: 9770188
    [No Abstract]   [Full Text] [Related]  

  • 47. Criteria for rebiopsy.
    Van Horn BM
    Am J Clin Pathol; 1998 Sep; 110(3):408-9. PubMed ID: 9728619
    [No Abstract]   [Full Text] [Related]  

  • 48. Report from Durham.
    Moul JW
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):1. PubMed ID: 20145629
    [No Abstract]   [Full Text] [Related]  

  • 49. Adductor myonecrosis following prostate biopsy.
    Braslis KG; Stephens DA
    Aust N Z J Surg; 1997 Dec; 67(12):900-2. PubMed ID: 9451351
    [No Abstract]   [Full Text] [Related]  

  • 50. Adenocarcinoma of the prostate: diagnostic techniques.
    Waisman J
    Hum Pathol; 1992 Oct; 23(10):1194-5. PubMed ID: 1398651
    [No Abstract]   [Full Text] [Related]  

  • 51. A new instrument for needle biopsy of the prostate.
    Mellinger GT; Blackard CE
    J Urol; 1968 Feb; 99(2):228-9. PubMed ID: 5641083
    [No Abstract]   [Full Text] [Related]  

  • 52. New possibilities for urinary molecular diagnostics.
    Culig Z
    BJU Int; 2016 Apr; 117(4):547-8. PubMed ID: 26969032
    [No Abstract]   [Full Text] [Related]  

  • 53. Length matters in prostate cancer.
    Siadat F; Sykes J; Van der Kwast TH
    Can J Urol; 2013 Aug; 20(4):6854. PubMed ID: 23930612
    [No Abstract]   [Full Text] [Related]  

  • 54. Prostate cancer diagnosis: even the experts disagree.
    Delahunt B
    Hum Pathol; 2006 Mar; 37(3):251-2. PubMed ID: 16613318
    [No Abstract]   [Full Text] [Related]  

  • 55. Editorial comment to prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.
    Fukuhara H
    Int J Urol; 2011 Aug; 18(8):568-9. PubMed ID: 21692867
    [No Abstract]   [Full Text] [Related]  

  • 56. Needle biopsy in carcinoma of the prostate.
    Scott R
    JAMA; 1967 Sep; 201(12):958-60. PubMed ID: 6072636
    [No Abstract]   [Full Text] [Related]  

  • 57. [The value of the penumbra in targeted prostate biopsy].
    Saner Y; Tschirdewahn S
    Urologie; 2023 Jan; 62(1):75-76. PubMed ID: 36319707
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostatic percutaneous biopsy.
    DE LA PENA A; CAVANAUGH RJ; BALLARD LG
    Urol Int; 1961; 12():1-5. PubMed ID: 13720586
    [No Abstract]   [Full Text] [Related]  

  • 59. [Direct prostatic biopsy].
    DEVOS R
    Acta Urol Belg; 1955 Jul; 23(3):269-72. PubMed ID: 13275352
    [No Abstract]   [Full Text] [Related]  

  • 60. Point-Counterpoint: Screening vs Diagnostic Testing: A Focus on the Improved Evaluations and Risk Adapted Strategies for Prostate Biopsy.
    Davis JW
    Urol Pract; 2023 Mar; 10(2):109-110. PubMed ID: 37103400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.